Table 3.
Antimicrobial activity expressed as Minimum Inhibition Concentration (MIC, μg/mL).
| Compound No | Gram-Positive Organisms | Gram-Negative Organisms | Fungi | |||||
|---|---|---|---|---|---|---|---|---|
| Sp | Bs | Sa | Pa | Ec | Kp | Af | Ca | |
| 2a | 31.25 | 31.25 | 16 | 31.25 | 16 | 31.25 | 125 | 62.5 |
| 2b | 31.25 | 31.25 | 16 | 16 | 16 | 31.25 | 125 | 125 |
| 2c | 16 | 31.25 | 16 | 16 | 16 | 16 | 125 | 62.5 |
| 3a | 31.25 | 16 | 16 | 16 | 16 | 31.25 | 62.5 | 31.25 |
| 3b | 31.25 | 16 | 16 | 16 | 16 | 31.25 | 31.25 | 31.25 |
| 3c | 16 | 16 | 16 | 16 | 16 | 16 | 31.25 | 31.25 |
| 5a | 16 | 16 | 16 | 16 | 16 | 16 | 31.25 | 31.25 |
| 5b | 16 | 16 | 16 | 16 | 16 | 16 | 31.25 | 31.25 |
| 5c | 16 | 8 | 8 | 16 | 8 | 16 | 16 | 16 |
| 5d | 16 | 16 | 8 | 8 | 8 | 16 | 31.25 | 31.25 |
| 5e | 8 | 8 | 8 | 8 | 8 | 16 | 16 | 16 |
| 5f | 8 | 8 | 8 | 8 | 8 | 16 | 16 | 16 |
| 5g | 16 | 16 | 16 | 16 | 16 | 16 | 31.25 | 31.25 |
| 5h | 16 | 16 | 16 | 16 | 16 | 16 | 31.25 | 31.25 |
| 5i | 8 | 8 | 8 | 16 | 8 | 8 | 16 | 16 |
| 5g | 16 | 8 | 8 | 8 | 8 | 8 | 31.25 | 31.25 |
| 5k | 8 | 8 | 8 | 8 | 8 | 8 | 16 | 16 |
| 5l | 8 | 8 | 8 | 8 | 8 | 8 | 16 | 16 |
| 5m | 8 | 8 | 16 | 8 | 8 | 16 | 16 | 16 |
| 5n | 8 | 16 | 8 | 8 | 8 | 16 | 16 | 16 |
| 5o | 8 | 8 | 4 | 4 | 8 | 8 | 8 | 8 |
| 5p | 8 | 8 | 8 | 16 | 8 | 8 | 16 | 8 |
| 5q | 4 | 4 | 8 | 4 | 4 | 8 | 4 | 4 |
| 5r | 4 | 4 | 8 | 4 | 4 | 8 | 4 | 4 |
| Ciprofloxacin | ≤4 | ≤1 | ≤4 | ≤4 | ≤1 | ≤1 | - | - |
| Fluconazole | - | - | - | - | - | - | ≤1 | ≤1 |
Sp: Streptococcus pneumonia; Bs: Bacillus subtilis; Sa: Staphylococcus aureus; Pa: Pseudomonas aeuroginosa; Ec: Escherichia coli; Kp: Klebsiella pneumonia; Af: Aspergillus fumigates; Ca: Candida albicans.